Zhang Yaqi, Bai Yingnan, Jing Qing, Qian Juying
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Lymphat Res Biol. 2018 Dec;16(6):507-515. doi: 10.1089/lrb.2018.0023. Epub 2018 Oct 19.
Cardiac lymphatic vessels play a vital role in maintaining cardiac homeostasis both under physiological and pathological conditions. Clearer illustration of the anatomy of cardiac lymphatics has been achieved by fluorescence exhibition comparing to dye injection. Besides, identification of specific lymphatic markers in recent decades paves the way for researches in development and regeneration of cardiac lymphatics, such as VEGF-C/VEGFR-3, EphB4/ephrin-B2, Prox-1, Podoplanin, and Lyve-1. Knocking out each of these markers in mice model also reveals the signaling pathways instructing the formation of cardiac lymphatics. In the major cardiovascular disease series of atherosclerosis, myocardial infarction (MI), and heart failure, cardiac lymphatics regulate the transportation of extravasated proteins and lipids, inflammatory and immune responses, as well as fluid balance. Elementary intervention methods, such as lymphatic factor protein injection VEGF-C, are applied in murine MI models to restore or enhance functions of lymphatic vessels, achieving improvements in cardiac function. Also, data from our laboratory showed that intramyocardial EphB4 injection also improved lymphatic regeneration in mouse MI model. Therefore, we believe that enhancing functions and regeneration of mature cardiac lymphatic vessels in cardiovascular diseases is of great potential therapeutic meaning in the future.
心脏淋巴管在生理和病理条件下对维持心脏内环境稳定起着至关重要的作用。与染料注射相比,通过荧光显示已更清晰地阐明了心脏淋巴管的解剖结构。此外,近几十年来特定淋巴管标志物的鉴定为心脏淋巴管发育和再生的研究铺平了道路,如血管内皮生长因子C/血管内皮生长因子受体-3、EphB4/ Ephrin-B2、Prox-1、血小板内皮细胞黏附分子-1和淋巴管内皮透明质酸受体-1。在小鼠模型中敲除这些标志物中的每一种也揭示了指导心脏淋巴管形成的信号通路。在动脉粥样硬化、心肌梗死(MI)和心力衰竭等主要心血管疾病系列中,心脏淋巴管调节外渗蛋白质和脂质的运输、炎症和免疫反应以及液体平衡。在小鼠MI模型中应用了诸如注射淋巴管因子蛋白血管内皮生长因子C等基本干预方法,以恢复或增强淋巴管功能,从而改善心脏功能。此外,我们实验室的数据表明,心肌内注射EphB4也改善了小鼠MI模型中的淋巴管再生。因此,我们认为增强成熟心脏淋巴管在心血管疾病中的功能和再生在未来具有巨大的潜在治疗意义。